UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maintenance treatment with bevacizumab in metastatic colorectal cancer: intermittent or continuous therapy? A monoinstitutional observational study

Annals of oncology, 2017-10, Vol.28, p.vi12-vi12

2017

Volltextzugriff (PDF)

Chemotherapy in pancreatic adenocarcinoma

European review for medical and pharmacological sciences, 2010-04, Vol.14 (4), p.386

2010

Volltextzugriff (PDF)

Neuroendocrine tumour arising inside a retro-rectal tailgut cyst: report of two cases and a review of the literature

Ecancermedicalscience, 2011-02, Vol.5, p.201

2011

Volltextzugriff (PDF)

1750P Clinical course and outcome of COVID-19 in cancer patients: Early results from the “onCOVID-19” study

Annals of oncology, 2020-09, Vol.31, p.S1021-S1021

2020

Volltextzugriff (PDF)

459P Dynamic changes of pro-angiogenic factors during FOLFIRI-aflibercept treatment: Interim analysis of DISTINCTIVE trial

Annals of oncology, 2021-09, Vol.32, p.S562-S562

2021

Volltextzugriff (PDF)

Right pelvic mass in a patient with a radically resected carcinoid of the appendix

Gut, 2009-09, Vol.58 (9), p.1200-1200

2009

Volltextzugriff (PDF)

Clinical management of metastatic gastric cancer: a single center experience

Annals of oncology, 2016-09, Vol.27, p.iv26

2016

Volltextzugriff (PDF)

467P Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial

Annals of oncology, 2021-09, Vol.32, p.S565-S565

2021

Volltextzugriff (PDF)

Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

Annals of oncology, 2019-10, Vol.30, p.v308-v309

2019

Volltextzugriff (PDF)

801PEfficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

801P - Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

Annals of oncology, 2019-10, Vol.30, p.v308-v309

2019

Volltextzugriff (PDF)

Second line chemotherapy for gastric cancer: a single center experience

Annals of oncology, 2015-10, Vol.26, p.vi100

2015

Volltextzugriff (PDF)

Adjuvant chemotherapy in stage II and III resected gastric cancer: clinical data from a single center experience

Annals of oncology, 2016-09, Vol.27, p.iv26

2016

Volltextzugriff (PDF)

HER-2 in gastric cancer: a single institution experience

Annals of oncology, 2016-09, Vol.27, p.iv26

2016

Volltextzugriff (PDF)

Weekly cisplatin, leucovorin and 5Fluorouracile (PFL) as first line chemotherapy in selected patients with advanced gastric cancer

Annals of oncology, 2016-09, Vol.27, p.iv27

2016

Volltextzugriff (PDF)

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Annals of oncology, 2016-09, Vol.27, p.iv9

2016

Volltextzugriff (PDF)

Ramucirumab as second line therapy in metastatic gastric cancer (MGC): results of the Italian compassionate-use named patients. The RAMoss study

Annals of oncology, 2016-09, Vol.27, p.iv17

2016

Volltextzugriff (PDF)

Carboplatin with etoposide in patients with extrapulmonary “aggressive” neuroendocrine carcinoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13072-e13072

2010

Volltextzugriff (PDF)

Metronomic capecitabine in advanced well or moderately differentiated neuroendocrine carcinomas

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13130-e13130

2010

Volltextzugriff (PDF)

Hepatic intra-arterial chemotherapy in patients with advanced hepatocellular and biliary tract carcinomas using a temporary percutaneous catheter

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14622-e14622

2010

Volltextzugriff (PDF)

Multimodal treatment of nodal localizations from Merkel cell carcinoma with no identifiable primary site and distant metastases

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e19020-e19020

2010

Volltextzugriff (PDF)

Ca 19.9 as an early predictor of response to first- and second-line treatment in patients with pancreatic cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.15547-15547

2008

Volltextzugriff (PDF)

Efficacy and toxicity of a low dose regimen of capecitabine and oral vinorelbine

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.12013-12013

2008

Volltextzugriff (PDF)

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice

Expert opinion on therapeutic targets, 2006-04, Vol.10 (2), p.281-287

2006

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) status in different stages of resected non-small cell lung cancer (NSCLC): Implications for treatment with EGFR-targeted monoclonal antibodies

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.20015-20015

2006

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Humans
(6)
Male
(4)
Middle Aged
(3)
Adult
(2)
Aged
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Female
(2)
Pharmacology & Pharmacy
(2)
Treatment Outcome
(2)
Young Adult
(2)
5-Fu
(1)
Adenocarcinoma - Drug Therapy
(1)
Adenocarcinoma - Pathology
(1)
Adjuvant
(1)
Adolescent
(1)
Aged, 80 And Over
(1)
Aging
(1)
Animals
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maintenance treatment with bevacizumab in metastatic colorectal cancer: intermittent or continuous therapy? A monoinstitutional observational study

Chemotherapy in pancreatic adenocarcinoma

Neuroendocrine tumour arising inside a retro-rectal tailgut cyst: report of two cases and a review of the literature

1750P Clinical course and outcome of COVID-19 in cancer patients: Early results from the “onCOVID-19” study

459P Dynamic changes of pro-angiogenic factors during FOLFIRI-aflibercept treatment: Interim analysis of DISTINCTIVE trial

Right pelvic mass in a patient with a radically resected carcinoid of the appendix

Clinical management of metastatic gastric cancer: a single center experience

467P Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial

Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

801PEfficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

801P - Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

Second line chemotherapy for gastric cancer: a single center experience

Adjuvant chemotherapy in stage II and III resected gastric cancer: clinical data from a single center experience

HER-2 in gastric cancer: a single institution experience

Weekly cisplatin, leucovorin and 5Fluorouracile (PFL) as first line chemotherapy in selected patients with advanced gastric cancer

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Ramucirumab as second line therapy in metastatic gastric cancer (MGC): results of the Italian compassionate-use named patients. The RAMoss study

Carboplatin with etoposide in patients with extrapulmonary “aggressive” neuroendocrine carcinoma

Metronomic capecitabine in advanced well or moderately differentiated neuroendocrine carcinomas

Hepatic intra-arterial chemotherapy in patients with advanced hepatocellular and biliary tract carcinomas using a temporary percutaneous catheter

Multimodal treatment of nodal localizations from Merkel cell carcinoma with no identifiable primary site and distant metastases

Ca 19.9 as an early predictor of response to first- and second-line treatment in patients with pancreatic cancer

Efficacy and toxicity of a low dose regimen of capecitabine and oral vinorelbine

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice

Epidermal growth factor receptor (EGFR) status in different stages of resected non-small cell lung cancer (NSCLC): Implications for treatment with EGFR-targeted monoclonal antibodies

Suchergebnisse filtern